Skip to main content
. 2014 Dec 12;4(1):1–19. doi: 10.1007/s40123-014-0027-6

Fig. 1.

Fig. 1

Kaplan–Meier time to uveitis recurrence for implanted study eyes versus nonimplanted fellow eyes in the 0.59- and 2.1-mg implant group. Discontinued patients were censored following their last visit. P < 0.001 for the within-treatment difference comparison of study eye versus fellow eye; P = 0.0062 for the between-treatment difference in implanted eyes